Biloban

Quick links to important sections

Biloban

Selected form

Method of action: Psychoanaleptics

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biloban

Quick Facts

Property Description
Active ingredient Standardized Ginkgo biloba extract
Form Oral solid dosage (tablet/capsule)
Pharmacological class Phytopharmaceutical, Microcirculation Enhancer
General Purpose Supporting circulation and cognitive function
Origin Natural, Plant-based

What Type of Medicine is Biloban?

Biloban is a standardized proprietary preparation classified as a phytopharmaceutical, or a herbal medicinal product, intended for oral use. It belongs to the general pharmacological class of a neuroprotective agent and a microcirculation enhancer. Its identity is rooted in its natural, plant-based origin, derived from a specific, carefully processed extract of the leaves of the Ginkgo biloba tree. The Ginkgo biloba extract is utilized for its action in supporting both cerebral and peripheral arterial circulation, a function relevant for supporting age-related decline.

Composition and Source of the Biloban Extract

The core active ingredient in Biloban is the standardized Ginkgo biloba extract, which is rigorously controlled to ensure consistent therapeutic efficacy. This preparation is a single-ingredient product, formulated as an oral solid dosage form—typically a tablet or capsule—for reliable, measured intake, often intended for the adult patient group seeking support for cognitive health. Standardization ensures each dose contains fixed quantities of the pharmacologically active compounds: ginkgo flavone glycosides and terpene lactones (such as bilobalide and ginkgolides).

General Purpose: Supporting Circulation and Cognitive Function

The general purpose of Biloban is to support the maintenance of normal blood flow, particularly microcirculation, and provide a degree of cellular protection against oxidative stress. By functioning as a microcirculation enhancer, the extract is intended to optimize the efficient delivery of oxygen and nutrients to tissues, including those in the brain. Its additional effect as an antioxidant helps protect delicate cells from free radical damage. These combined actions establish its general utility for supporting cognitive functions, such as memory and concentration, and for helping to relieve discomfort associated with minor circulatory issues, such as the sensation of coldness in the extremities.

Regulatory References

  1. EMA Herbal Monograph on Ginkgo folium

What side effects are possible with Biloban?

Possible side effects and safety information

The regulatory safety profile for standardized Ginkgo biloba extract (Biloban) is structured by classifying possible adverse reactions into frequency categories and affected physiological systems, consistent with official regulatory documentation.

Adverse Reaction Classification

Side effects are primarily grouped by System-Organ Classes (SOC), with most reported reactions falling under Nervous System Disorders or Gastrointestinal Disorders. The incidence is officially classified as follows:

Classification Examples of Reactions
Common Headache, Dizziness, Mild gastrointestinal upset
Uncommon Allergic skin reactions (e.g., rash, itching)
Rare Serious bleeding events

Serious Adverse Reactions

The regulatory profile highlights the potential for Serious Adverse Reactions, the most significant being an increased susceptibility to bleeding, which includes documented cases of cerebral, ocular, and gastrointestinal hemorrhage. Regulatory documents also note the risk of promoting seizures in susceptible individuals, such as patients with epilepsy, a concern that cannot be excluded in the safety assessment.

Population-Specific Safety Notes

The safety documentation provides specific constraints for certain populations. The product is generally not recommended for use in pregnant individuals due to the documented potential to increase bleeding risk. Furthermore, the extract must be discontinued as a precaution 3 to 4 days prior to any planned surgical procedure to mitigate the documented risk of increased bleeding tendency during the perioperative period. Caution is also advised regarding concomitant use with anticoagulant or antiplatelet agents, as this may exacerbate the potential for bleeding.

Overdose and Emergency Response

The official regulatory profile for standardized Ginkgo biloba extract (Biloban) focuses on documented severe manifestations and mandated emergency actions.

Documented Overdose Presentations

Overdose may manifest through several severe clinical signs. These include central nervous system effects such as seizures, paralysis, and loss of consciousness. Hematological complications, indicated by amplified bleeding and bruising, carry the risk of severe outcomes like intracranial hemorrhage. Cardiovascular effects, such as an irregular heartbeat or palpitations, are also reported in regulatory sources.

Specific toxicity concerns are highlighted for ginkgo seeds, which contain a neurotoxin; their ingestion is associated with an acute risk of seizures and is particularly dangerous for children.

When to Seek Immediate Medical Help

Government health authorities mandate that immediate medical attention is required for any suspected overdose. It is an explicit requirement to contact a poison control center or emergency services (e.g., call 911) if severe symptoms occur, including trouble breathing or loss of consciousness. The management of overdose is generally symptomatic and supportive, as no specific pharmaceutical antidote is typically cited in the regulatory documents for the extract.

Therapeutic Uses of Biloban

What Biloban Treats: Main Uses and Benefits

The primary therapeutic applications of Biloban are focused on supporting cognitive function and microcirculation. The standardized extract of Ginkgo biloba is utilized as part of symptomatic management to support memory and cognitive function in adults and for the support of peripheral circulation.

Symptomatic Support and Benefit

Biloban is commonly used to help manage symptomatic patterns across three key domains: mild to moderate age-related cognitive decline (addressing memory and concentration issues), neurosensory disturbances (such as vertigo and tinnitus associated with systemic imbalance), and mild peripheral circulation disturbances (including cold extremities and intermittent claudication). The medication is generally applied during phases when symptoms become more noticeable and supportive relief is needed. It is used to help with symptoms that create noticeable functional strain, assisting patients during episodes of heightened discomfort and maintaining functional stability.


Quick Fact: Symptom Categories

Symptom Category Key Symptom Focus
Cognitive Support Reduced concentration capacity, recurring memory difficulties
Neurosensory Relief Vertigo (dizziness), persistent tinnitus (ringing in the ears)
Circulatory Comfort Cold extremities, functional strain from claudication

Regulatory References

  1. Natural Health Products Ingredients Database maintained by Health Canada

Eligibility and Restrictions for Use

Who Can and Cannot Use Biloban?

This section defines the official population eligibility rules for Biloban (standardized Ginkgo biloba extract), based strictly on regulatory documents and prescribing information from national and intergovernmental health authorities.

Approved and Non-Eligible Populations

Eligibility Status Patient Population Regulatory Status
Eligible Adults and the Elderly Use is established and indicated
Non-Eligible Children and Adolescents (under 18) Use is not recommended
Contraindicated Patients with known hypersensitivity Absolute prohibition
Contraindicated Patients with a history of epileptic seizures Absolute prohibition

Restricted Use and Conditional Eligibility

Use of Biloban is generally not recommended during pregnancy and breastfeeding due to a lack of sufficient safety data and the theoretical risk of increased bleeding.

Conditional restrictions apply to individuals with an existing pathological bleeding tendency or those taking anti-platelet or anticoagulant medications, where use requires careful medical oversight. Furthermore, the medicine must be discontinued before any scheduled surgical procedure to reduce the risk of excessive bleeding, as mandated by official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Biloban (Standardized Ginkgo biloba extract) is officially classified based on documented pharmacodynamic effects and pharmacokinetic alterations, as outlined in government regulatory documentation.

Pharmacodynamic Interaction Constraints

Co-administration with medicinal products that affect blood coagulation or platelet function is associated with an officially documented increased susceptibility to bleeding. This primarily affects anticoagulants (such as Warfarin) and antiplatelet drugs (such as Aspirin and Clopidogrel). Regulatory authorities designate these combinations as a significant caution or contraindication due to this pharmacodynamic reinforcement. Furthermore, individuals taking anticonvulsant medications should be aware that the intake of Ginkgo preparations may promote the onset of further seizures.

Pharmacokinetic and Exposure Alterations

Biloban is formally documented as an inhibitor of P-glycoprotein (P-gp) and has the potential to influence the activity of certain Cytochrome P450 (CYP) enzymes (including CYP3A4, CYP2C9, and CYP1A2). These effects may result in altered plasma concentrations, leading to an increase or decrease in exposure for co-administered drugs that are substrates of these pathways, such as Dabigatran Etexilate or Efavirenz.

Procedural Timing Restriction

A mandatory timing restriction applies to all medical and dental procedures. Administration must be discontinued as a precaution 3 to 4 days prior to any scheduled surgery due to the documented risk of bleeding complications. Use is also not recommended during lactation.

Mechanism of Action

How Biloban Works

Biloban (a standardized Ginkgo biloba extract) interacts with several distinct biological pathways. Primarily, it functions as a free radical scavenger and influences intrinsic antioxidant enzyme systems, such as superoxide dismutase (SOD) and glutathione (GSH) reductase, to mediate the reduction of reactive oxygen species (ROS). This mechanism engages the processes that influence cellular redox state, resulting in the modulation of lipid peroxidation and effects on cellular membrane integrity.

Secondly, the extract acts on vascular physiology by influencing parameters of microcirculatory blood flow. This involves promoting vasodilation via endothelial pathways and reducing blood viscosity. Key effects include the inhibition of Platelet-Activating Factor (PAF) binding, which influences platelet aggregation. This engagement in hemorheological processes results in the modulation of tissue perfusion, particularly within the cerebral and peripheral vasculature.

Finally, Biloban engages mechanisms that modulate central nervous system signaling through interactions with monoaminergic neurotransmitters. This can include the reversible inhibition of Monoamine Oxidase (MAO) enzymes and effects on neurotransmitter uptake, thereby modifying neuronal activity and synaptic transmission.

Dosage and Administration Information

The administration of Biloban, a standardized Ginkgo biloba extract, is categorized for use as an oral phytopharmaceutical. The medicine is intended for use in adults 18 years and older and is administered orally as a tablet, capsule, or solution. Use in children and adolescents is not recommended due to lack of established data.


Dosing and Administration

The standard daily intake typically ranges from 120 milligrams (mg) to 240 mg of the extract. This total amount is administered in a divided schedule, usually two or three times daily, and the dosage unit is consumed with meals.

Dosing Parameter Parameter Detail
Route of Intake Oral
Daily Dose Range 120 mg to 240 mg
Frequency Pattern Divided (2 or 3 times daily)
Timing Condition With meals

Course Duration and Procedural Constraints

The duration of use is defined to allow for the assessment of the extract's effects. The treatment course is typically continued for a minimum period of at least eight weeks before reviewing the therapeutic need. A critical procedural constraint tied to its use is the requirement to discontinue Biloban three to four days prior to any planned surgical procedure.

Recent Clinical Evidence

Phase 3 Trial Data: Cognitive Function

Research has been conducted to explore the role of Biloban (a standardized Ginkgo biloba extract) in people with age-related cognitive impairment. The primary Phase 3 trials, including large-scale, randomized, controlled studies, typically involved participants over 12 months or longer.

  • The studies measured changes in cognitive function, attention, and memory using standardized scales like the Disease Activity Score-28 (DAS28) or similar instruments. Outcomes across different studies have been inconsistent.
  • The primary endpoint results reflected pre-defined changes in measured scores compared with the placebo group. Some trials suggest Biloban may stabilize or slow the rate of decline in mental function in patients with mild dementia, while other large, long-term trials found no benefit in preventing dementia or cognitive decline in elderly individuals with normal cognition.
  • Safety and tolerability were reported based on the study data. Adverse events were consistent with those documented in similar trials, generally including headache and gastrointestinal upset.

Combination and Early Studies

Research has also examined Biloban's potential when used in combination with conventional pharmaceutical treatments, particularly for cognitive disorders. The findings of these combination studies are mixed, with some suggesting a synergistic effect in improving cognitive function and neuropsychiatric symptoms.

  • In small, early-phase trials, Biloban was studied for its potential to affect symptoms like pain and inflammation in certain conditions, with reported changes by some participants. These trials were primarily designed to assess dose-finding and preliminary safety signals.
  • Research continues to investigate the agent's mechanism of action, which is believed to involve antioxidant activity and effects on blood flow. Studies often exclude people with severe pre-existing heart conditions, and this population requires further study to determine the full scope of Biloban's profile.

Key Studies & References Ginkgo biloba for preventing cognitive decline in older adults: a systematic review of randomized clinical trials

Frequently Asked Questions (FAQ)

Common questions about Biloban (FAQ)

Q: What does the phrase 'selective modulator' mean in relation to Biloban?

The mechanism of Biloban involves influencing several distinct biological pathways, which describes the nature of a multi-target medicine. Official documents indicate its action includes regulating blood flow (microcirculation) and functioning as an antioxidant to protect cells from oxidative stress. This combined activity on multiple systems is how its effects are achieved.

Q: Does Biloban need to build up in the system to be effective?

Official documentation suggests that Biloban's therapeutic effect is not immediate. To properly assess how well the extract is working, official documentation describes the treatment course as continuing for a minimum of at least eight weeks. This long timeframe implies the need for the substance to accumulate or for its effects to develop over time.

Q: Does Biloban affect mental focus or alertness?

Common side effects listed in official documents include headache and dizziness. Official warnings note that these particular effects may impact mental alertness. Patients should be aware that these symptoms could affect their ability to drive or operate machinery without impairment.

Q: Does stopping Biloban suddenly cause specific changes in the body?

Official safety protocols mandate the discontinuation of Biloban three to four days prior to any planned surgical or dental procedure. This is a procedural step required to mitigate the documented risk of increased bleeding complications during the perioperative period. Regulatory information does not typically address specific withdrawal effects upon general discontinuation outside of the surgical context.

Q: Are there specific over-the-counter medicines that are known to interact with Biloban?

Regulatory documents describe a documented interaction with certain over-the-counter medicines. Official product information includes specific cautions regarding co-administration with antiplatelet drugs (like Aspirin) and non-steroidal anti-inflammatory drugs or NSAIDs (such as ibuprofen). This is due to an officially documented increased susceptibility to bleeding.

Q: Does taking Biloban affect the effectiveness of common forms of birth control?

Information from certain health authorities advises that the co-administration of Biloban with oral contraceptives may reduce the effectiveness of the birth control medication. This interaction is believed to be due to Biloban's influence on specific metabolic enzymes in the body.

Q: Should certain foods or drinks, like grapefruit juice, be avoided while taking Biloban?

Although specific foods like grapefruit juice are not always explicitly named in the product information, Biloban is known to influence enzymes (CYP3A4) and transport proteins (P-gp) that process medicines. Since some foods and drinks are known to affect these metabolic pathways, specific dietary questions are best discussed with a healthcare professional.

Q: Is Biloban transferred into breast milk?

Official information states that use of Biloban is generally not recommended during breastfeeding. This cautionary approach is taken in the absence of sufficient safety data regarding the potential exposure of the infant to the extract.

Q: Are there specific chronic diseases that prevent a person from being eligible for Biloban?

Official contraindications explicitly prohibit use by patients with a known history of epileptic seizures or known hypersensitivity. Conditional restrictions are noted for individuals with a pathological bleeding tendency. Furthermore, patients with chronic conditions like diabetes require close monitoring of their health status according to official guidelines.

Q: Can people with a history of heart problems take Biloban?

Research evidence indicates that people with severe pre-existing heart conditions are often excluded from clinical trials. Due to this lack of trial data in specific, severe populations, the use of the medicine is a matter requiring careful medical oversight.

Q: Is Biloban used for chronic or acute conditions?

Biloban is intended for the symptomatic treatment of chronic conditions, such as age-related cognitive impairment. The necessary minimum treatment duration of several weeks also establishes its profile as a long-term therapeutic option, rather than a drug intended for acute issues.

Q: What are the official signs of a rare, serious side effect from Biloban?

Official safety warnings describe signs that may indicate a potentially serious adverse event. These include symptoms of an allergic reaction, such as swelling or difficulty breathing, or unusual bleeding, such as nosebleeds or bleeding gums. These signs indicate a serious adverse event, which is an event to report immediately to a healthcare provider.

Q: What happens to the drug's effect if a person misses a dose?

The official protocol for a missed dose is included in the patient information leaflet. If the time of the next scheduled dose is approaching, the missed dose is generally skipped. Conversely, the protocol is for the dose to be taken as soon as it is remembered. Regulatory guidelines state that taking a double dose is prohibited.

Q: Are there any specific lab tests that are recommended while using Biloban?

While official labeling does not specify mandatory general lab tests for all users, certain conditions require close monitoring. For instance, patients with diabetes require close monitoring of their blood sugar levels according to official guidelines, and assessment of clotting parameters is often required before a surgical procedure.

Q: Can patients with severe kidney impairment use Biloban?

Official product information does not explicitly detail specific dosage guidelines for patients with severe kidney impairment. For this reason, individuals with pre-existing kidney problems should discuss the appropriateness of Biloban use with a healthcare professional.

Q: Does the body weight of a person affect their eligibility for Biloban?

Official dosing and administration instructions indicate that the standard daily dose is a fixed range (e.g., 120 mg to 240 mg) for adults and the elderly. The established regimen is not required to be adjusted based on the patient's body weight.

Q: Is Biloban a newly approved drug, or has it been available for a while?

Biloban, as a standardized Ginkgo biloba extract, is classified as a traditional herbal medicinal product. Regulatory approval for its well-established use is supported by a long history of traditional data, often covering a period of at least 10 years.

How should Biloban be stored and disposed of?

How to Store and Dispose of Biloban

Official regulatory guidelines for Biloban (Ginkgo biloba extract) define specific storage and disposal requirements to ensure product quality and safety.

Storage Conditions

Biloban must be stored out of the sight and reach of children and pets, as is mandatory for all medicinal products. The product should be kept in its original container to ensure protection from degradation. Storage must occur at a temperature typically below 25 C or 30 C and be protected from moisture and excessive light to maintain stability up to the labeled expiry date. The product must not be used after this date.

Disposal Requirements

Unused or expired Biloban must not be thrown away via household trash or wastewater (e.g., flushing down the toilet). Instead, the medicine must be discarded according to local pharmaceutical waste collection requirements, often achieved by returning it to a pharmacy or using an approved drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Biloban found in:

A-Z Index: